• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION POLYFLUX; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION POLYFLUX; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 109651
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dyspnea (1816); Hypersensitivity/Allergic reaction (1907); High Blood Pressure/ Hypertension (1908); Tachycardia (2095); Wheezing (4463)
Event Date 03/09/2024
Event Type  Injury  
Event Description
It was reported that ¿18 minutes¿ after starting dialysis treatment while using a polyflux dialyzer, the patient experienced ¿shortness of breath, dyspnea, dry and wet rale and wheezing in both lungs¿.The patient¿s heart rate was reported to be 130 beats per minute and the blood pressure was recorded as 167/84mmhg further reported as ¿increased significantly¿.Dialysis treatment was discontinued.As treatment for the symptoms, the patient was given intravenous infusions of dexamethasone 10 mg, 20ml of 10% calcium gluconate injection in 100 ml of normal saline, and amiodarone injection 150mg in 20 ml of 5% glucose.The patient was also given unspecified ¿other symptomatic treatment, such as anti-allergy, anti-arrhythmia¿ and oxygen inhalation.The patient¿s shortness of breath and dyspnea were reported to be ¿slightly relieved¿ approximately 30 minutes after treatment was given.The patient was transferred to the icu for bedside hemofiltration treatment and was reported to be ¿stable¿.No additional information is available.
 
Manufacturer Narrative
Should additional relevant information become available, a supplemental report will be submitted.
 
Manufacturer Narrative
Additional information has been added to h6 and h10: a batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POLYFLUX
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - HECHINGEN BADEN DIALYZER
holger - crafoord - strasse 26
hechingen D-723 79
GM   D-72379
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key19092302
MDR Text Key339982365
Report Number9611369-2024-00070
Device Sequence Number1
Product Code KDI
UDI-Device Identifier07332414086633
UDI-Public(01)07332414086633
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 04/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number109651
Device Lot Number3-5138-H-01
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/18/2024
Initial Date FDA Received04/11/2024
Supplement Dates Manufacturer Received04/19/2024
Supplement Dates FDA Received04/25/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-